UroGen Pharma (URGN) Change in Receivables (2017 - 2026)
UroGen Pharma (URGN) reported Change in Receivables of $33.35 million for Q2 2026, compared with $11,000 a year earlier and up 49.3% from the prior quarter.
Powered by 
Analysis
UroGen Pharma (URGN) Change in Receivables (2017 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, UroGen Pharma's Change in Receivables came in at $69.11 million; for FY2025, it came in at $12.78 million, up 163.0% from FY2024.
- Change in Receivables has increased for three consecutive years, with a five-year compound annual growth rate of 12.6% (FY2020 to FY2025).
- By year, Change in Receivables came in at $4.86 million in FY2024 (+77.4%), $2.74 million in FY2023 (+177.5%), $987,000 in FY2022 (-78.9%) and $4.67 million in FY2021 (-33.7%).
- The Q2 2026 figure ranks as the highest quarterly Change in Receivables in data going back to Q1 2017.
- The high point for year-over-year Change in Receivables in five years was Q2 2023 (growth of 43.7%); the low point was Q2 2025 (a decline of 99.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $22.33 million (Q1 2026), $13.38 million (Q4 2025) and $54,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.35 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.37 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.09 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 333.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 140.20 Mn |
| 10 | UroGen Pharma | 1.99 Bn | 1.49 Bn | 65.88 Mn | 33.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33.35 Mn |
| Mar 31, 2026 | 22.33 Mn |
| Dec 31, 2025 | 13.38 Mn |
| Sep 30, 2025 | 54,000.00 |
| Jun 30, 2025 | 11,000.00 |
| Mar 31, 2025 | -664,000.00 |
| Dec 31, 2024 | -2.50 Mn |
| Sep 30, 2024 | 5.39 Mn |
| Jun 30, 2024 | 3.26 Mn |
| Mar 31, 2024 | -1.29 Mn |
| Dec 31, 2023 | 2.60 Mn |
| Sep 30, 2023 | -2.66 Mn |
| Jun 30, 2023 | 3.01 Mn |
| Mar 31, 2023 | -211,000.00 |
| Dec 31, 2022 | 3.28 Mn |
| Sep 30, 2022 | -2.17 Mn |
| Jun 30, 2022 | 2.10 Mn |
| Mar 31, 2022 | -2.22 Mn |
| Dec 31, 2021 | 3.93 Mn |
| Sep 30, 2021 | -1.73 Mn |
API Access
UroGen Pharma Change in Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-receivables&ticker=URGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-receivables", "ticker": "URGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-receivables&ticker=URGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();